Product Reports Resources Pricing Login Book a demo
Helene Peyro-Saint-Paul
Person profile

Helene Peyro-Saint-Paul

Strong founder
5
Companies backed
1
Companies founded
$29M
Total funding raised
3 schools
Education

Investments 5

Companies backed, as recorded by Dealroom. Highest company valuations first.

Sensome
Novadiscovery
Blue Bees Therapeutics
Urgenceschrono
ETISENSE SAS

Companies founded

Currently

Active roles, board seats and partnerships.

Blue Bees Therapeutics
Board Member · Investor · 2022 – present
EIT Health
2021 – present
GAOMA Therapeutics
Board Member · 2021 – present
MiMARK
Advisor · Business · 2021 – present
C4Diagnostics
2019 – present

Work history

Past roles by Dealroom records.

PathoQuest
CMO · 2015 – 2018
Qiagen
CMO · 2008 – 2015
Bristol-Myers Squibb
CEE Medical Affairs Lead for IBD · 2007 – 2008
Revlimid
2007 – 2008
Actelion Pharmaceuticals
Brand · Leader · 2003 – 2007
Johnson & Johnson Innovative Medicine
2003 – 2007
EMD Serono
Marketing Director · 1999 – 2003

Education

ESSEC Business School
Executive MBA · until 1999
University of Paris 13
Economics · until 1993
University of Toulouse
PhD · until 1991
← All people